Cancer remains the leading cause of death worldwide despite advances in treatment
options for patients. As such, safe and effective therapeutics are required. Short peptides …

Recent estimates indicate that tuberculosis (TB) is the leading cause of death worldwide,
alongside the human immunodeficiency virus (HIV) infection. The current treatment is …

The appearance and rapid spread of drug resistant strains of tuberculosis (TB), one of the
deadliest infectious diseases, pose a serious threat to public health and increase the need …

Peptide–drug conjugates are organic molecules composed of (i) a small drug molecule,(ii) a
peptide and (iii) a linker. The drug molecule is mandatory for the biological action, however …

One of the main hallmarks of tuberculosis (TB) is the ability of the causative agent to
transform into a stage of dormancy and the capability of long persistence in the host …

Nanobiotechnology has offered new approaches for drug delivery and for the development
of medicines against microbial infections including the deadly multidrug-resistant …

Abstract Ethnopharmacological relevance Tuberculosis (Tb) is one of the most infectious
diseases caused by Mycobacterium tuberculosis (Mt) with almost 2 million deaths yearly …

Aiming to improve the treatment outcomes of current daily tuberculosis (TB) chemotherapy
over several months, we investigated whether nanoencapsulation of existing drugs would …

Mycobacterium tuberculosis is an intracellular pathogen and the uptake of the
antimycobacterial compounds by host cells is limited. Novel antimycobacterials effective …

Cationic peptides proved fundamental importance as pharmaceutical agents and/or drug
carrier moieties functioning in cellular processes. The comparison of the in vitro activity of …